Young Li
Stock Analyst at Jefferies
(0.34)
# 3,951
Out of 4,789 analysts
5
Total ratings
33.33%
Success rate
-16.95%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $25.25 | +185.15% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $84.35 | +36.34% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.72 | +74.51% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $38.21 | +57.03% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $15.03 | +206.05% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $25.25
Upside: +185.15%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $84.35
Upside: +36.34%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.72
Upside: +74.51%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $38.21
Upside: +57.03%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $15.03
Upside: +206.05%